Navigating Aetna Breztri Prior Authorization for COPD Management

Aetna Prior Authorization Submission Channels for Breztri

Aetna, part of CVS Health, administers pharmacy benefit prior authorizations for drugs like Breztri primarily through its PBM, CVS Caremark. For retail and mail-order pharmacy benefit submissions, Aetna leverages ePA partners such as CoverMyMeds and Surescripts. While medical benefit precertification often routes through the Availity provider portal or X12 278 transactions, Breztri typically falls under the pharmacy benefit, requiring adherence to the PBM's specific electronic channels.

Accessing Aetna's Medical Necessity Criteria for Breztri

Aetna publishes its medical necessity criteria in detailed Clinical Policy Bulletins (CPBs), which are publicly available in the Aetna CPB library. Each CPB is versioned and dated, serving as the canonical source for coverage requirements. For Breztri, relevant CPBs will outline specific indications, step therapy requirements, quantity limits, and other clinical criteria that must be met for approval. Always reference the current CPB number and review date for accurate documentation.

Key Documentation Considerations for Aetna Breztri PA

• **Clinical History:** Detailed patient diagnosis, severity of COPD, and prior treatment regimens.
• **Step Therapy Compliance:** Documentation of trials and failures of preferred or lower-tier medications, as outlined in Aetna's CPBs.
• **Spirometry Results:** Objective evidence of lung function to support the diagnosis and medical necessity.
• **Adherence Documentation:** Proof of patient compliance with prescribed therapies.
• **Exclusion Criteria:** Verification that the patient does not meet any contraindications or exclusion criteria specified in Aetna's policy.

Understanding Aetna Breztri Prior Authorization Turnaround Times

Aetna's prior authorization turnaround times are influenced by state-mandated minimums, NCQA Utilization Management accreditation standards, and, for Medicare Advantage and Medicaid managed care plans (Aetna Better Health), the evolving requirements of CMS-0057-F. While commercial plans are subject to state and NCQA standards (historically 15 calendar days for non-urgent), CMS-0057-F mandates 72-hour decisions for standard PA and 24-hour for expedited requests for impacted lines of business, with phased compliance through 2027. Klivira's platform helps track these critical timelines.

Common Denial Reasons and Aetna's Appeal Pathway for Breztri

Denials for Breztri prior authorization often stem from insufficient documentation, failure to meet step therapy requirements, or lack of demonstrated medical necessity. Aetna returns denial reasons via X12 835/277 transactions using CARC and RARC codes, or through portal status updates. The appeal pathway typically includes reconsideration, peer-to-peer review, and formal appeals, with expedited options for urgent cases. Timely filing windows and external review eligibility vary by line of business and state regulations.

Klivira's Role in Automating Aetna Breztri Prior Authorization

Klivira integrates directly with your EMR system and connects with Aetna's various submission channels, including ePA partners like CoverMyMeds and Surescripts. Our platform automates the data extraction, form population, and submission process for Breztri, reducing manual effort and potential errors. By leveraging Klivira, your team can ensure adherence to Aetna's specific requirements, proactively manage step therapy protocols, and streamline the entire prior authorization workflow for respiratory medications.